A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in Korea

Clinical trial NCT01689220 · COMPLETED

Trial details

NCT number: NCT01689220
Sponsor: Solasia Pharma K.K.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Peripheral T-cell Lymphoma

Start date: 2012-09-01
Primary completion: 2014-01-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.